Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
04.01.20
OpGen and Curetis Successfully Close their Business Combination Transaction
03.30.20
OpGen Announces Shareholder Approval for Business Combination with Curetis
03.24.20
OpGen Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update for OpGen and Curetis Group

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events